Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:44:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T18:15:29.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:46:11.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:22:58.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options and fields related to clinical study information.
    Difference
    13%
    Check dated 2024-11-23T04:47:01.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    Several key government health and information websites have been removed from the monitored list.
    Difference
    0.7%
    Check dated 2024-11-15T23:56:29.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.